SCHEMBL797959

SCHEMBL797959

O=S(=O)(NC(F)(F)F)c1ccc(Br)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA2 P00918 3/20 0.55
MMP2 P08253 3/20 0.55
CA1 P00915 2/20 0.55
MMP1 P03956 2/20 0.55
MMP9 P14780 2/20 0.55
MMP13 P45452 2/20 0.55
MMP8 P22894 1/20 0.55
IDO1 P14902 2/20 0.50
FFAR1 O14842 1/20 0.46
FFAR4 Q5NUL3 1/20 0.46
F2 P00734 1/20 0.46
PRSS1 P07477 1/20 0.46
PRSS2 P07478 1/20 0.46
PRSS3 P35030 1/20 0.46
CA9 Q16790 2/20 0.44
CA12 O43570 1/20 0.44
CA14 Q9ULX7 1/20 0.44
MAPK1 P28482 1/20 0.44
HTT P42858 1/20 0.44
PLCG1 P19174 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16013940 0.81 MMP2 (0.48) CA2MMP2CA1MMP1MMP9
SCHEMBL27461771 0.79 CA1 (0.56) CA2MMP2CA1MMP1MMP9
SCHEMBL12054697 0.79 CA1 (0.53) CA2MMP2CA1MMP1MMP9
SCHEMBL2333640 0.79 ALDH1A1 (0.59) CA2MMP2CA1MMP1MMP9
SCHEMBL302571 0.78 GAA (0.55) CA2MMP2CA1MMP1MMP9
Hydrochloric Acid SCHEMBL2640192 0.77 GAA (0.54) CA2MMP2CA1MMP1MMP9
SCHEMBL1068742 0.76 MMP1 (0.50) CA2MMP2CA1MMP1MMP9
SCHEMBL8779438 0.76 CA2 (0.61) CA2MMP2CA1MMP1MMP9
SCHEMBL10005288 0.75 MMP2 (0.67) CA2MMP2CA1MMP1MMP9
SCHEMBL3013616 0.75 CA1 (0.51) CA2MMP2CA1MMP1MMP9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2616445-A2 ESTROGEN RECEPTOR MODULATORS AND USES THEREOF Aragon Pharmaceuticals, Inc. (US) 2013-07-24 EP disclosed
WO-2012037411-A9 ESTROGEN RECEPTOR MODULATORS AND USES THEREOF ARAGON PHARMACEUTICALS, INC. (US) 2012-05-18 WO disclosed
WO-2012037411-A2 ESTROGEN RECEPTOR MODULATORS AND USES THEREOF ARAGON PHARMACEUTICALS, INC. (US) 2012-03-22 WO disclosed